These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 37345635)

  • 1. The COVID-19 experience in Africa and the Middle East.
    Bizri AR; Al Akoury N; Mhlanga T; Morales GDC; Haridy H; Hussey GD; Srivastava A
    Ann Med; 2023 Dec; 55(1):2222641. PubMed ID: 37345635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward.
    Lawal L; Aminu Bello M; Murwira T; Avoka C; Yusuf Ma'aruf S; Harrison Omonhinmin I; Maluleke P; Tsagkaris C; Onyeaka H
    Hum Vaccin Immunother; 2022 Dec; 18(1):2034457. PubMed ID: 35240908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.
    Post L; Marogi E; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh L; White J; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Jan; 23(1):e25830. PubMed ID: 33302252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equitable and Feasible Distribution of SARS-CoV-2 Vaccines for All in Africa.
    Rogers AB; Barrie MB; Fallah MP; Kelly JD
    Am J Trop Med Hyg; 2021 Jun; 105(2):278-280. PubMed ID: 34181573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed Access to COVID-19 Vaccines: A Perspective on Low-income Countries in Africa.
    Hassan MA; Aliyu S
    Int J Health Serv; 2022 Jul; 52(3):323-329. PubMed ID: 35469499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations for Establishing Successful Coronavirus Disease Vaccination Programs in Africa.
    Williams V; Edem B; Calnan M; Otwombe K; Okeahalam C
    Emerg Infect Dis; 2021 Aug; 27(8):2009-2016. PubMed ID: 34138694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing vaccine hesitancy in Arab countries in the Middle East and North Africa (MENA) region: a scoping review protocol.
    Galal B; Lazieh S; Al-Ali S; Khoshnood K
    BMJ Open; 2022 Feb; 12(2):e045348. PubMed ID: 35149559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccine inequity in African low-income countries.
    Kunyenje CA; Chirwa GC; Mboma SM; Ng'ambi W; Mnjowe E; Nkhoma D; Ngwira LG; Chawani MS; Chilima B; Mitambo C; Crampin A; Mfutso-Bengo J
    Front Public Health; 2023; 11():1087662. PubMed ID: 36950103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.
    AlJamaan F; Temsah MH; Alhasan K; Alenezi S; Alhaboob A; Alrabiaah A; Batais M; Alshahrani F; Assiri RA; Bafaqih H; Alaraj A; Al Qadrah B; Alhaidary A; Saad K; Saddik B; Halwani R; Rabaan AA; Al-Subaie S; Barry M; Al-Tawfiq JA
    J Infect Public Health; 2022 Jul; 15(7):773-780. PubMed ID: 35728424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public acceptability of COVID-19 vaccines and its predictors in Middle ‎Eastern/North African (MENA) countries: a systematic review‎.
    Dadras O; SeyedAlinaghi S; Karimi A; Shamsabadi A; Mahdiabadi S; Mohammadi P; Amiri A; Shojaei A; Pashaei Z; Mirzapour P; Qaderi K; MohsseniPour M; Alilou S; Mehraeen E; Jahanfar S
    Hum Vaccin Immunother; 2022 Nov; 18(5):2043719. PubMed ID: 35318872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Healthcare Inequity: Lessons Learned from Annual Influenza Vaccination Rates to Mitigate COVID-19 Vaccine Disparities.
    Bazan IS; Akgün KM
    Yale J Biol Med; 2021 Sep; 94(3):509-515. PubMed ID: 34602888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa.
    Carcelen AC; Prosperi C; Mutembo S; Chongwe G; Mwansa FD; Ndubani P; Simulundu E; Chilumba I; Musukwa G; Thuma P; Kapungu K; Hamahuwa M; Mutale I; Winter A; Moss WJ; Truelove SA
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-6. PubMed ID: 34227914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccine hesitancy in Africa: a scoping review.
    Ackah BBB; Woo M; Stallwood L; Fazal ZA; Okpani A; Ukah UV; Adu PA
    Glob Health Res Policy; 2022 Jul; 7(1):21. PubMed ID: 35850783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccine equity in Africa.
    Turyasingura N; James WG; Vermund SH
    Trans R Soc Trop Med Hyg; 2023 Jun; 117(6):470-472. PubMed ID: 36622662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions.
    Tagoe ET; Sheikh N; Morton A; Nonvignon J; Sarker AR; Williams L; Megiddo I
    Front Public Health; 2021; 9():709127. PubMed ID: 34422750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine hesitancy among communities in ten countries in Asia, Africa, and South America during the COVID-19 pandemic.
    Harapan H; Anwar S; Yufika A; Sharun K; Gachabayov M; Fahriani M; Husnah M; Raad R; Abdalla RY; Adam RY; Khiri NM; Ismaeil MI; Ismail AY; Kacem W; Dahman NB; Teyeb Z; Aloui K; Hafsi M; Ferjani M; Deeb DA; Emad D; Abbas KS; Monib FA; Sami FS; Subramaniam R; Panchawagh S; Anandu S; Haque MA; Ferreto LE; Briones MF; Morales RB; Díaz SA; Aburto JT; Rojas JE; Balogun EO; Enitan SS; Yomi AR; Durosinmi A; Ezigbo ED; Adejumo EN; Babadi E; Kakemam E; Malik NI; Ullah I; Rosiello DF; Emran TB; Wendt GW; Arab-Zozani M; Wagner AL; Mudatsir M
    Pathog Glob Health; 2022 Jun; 116(4):236-243. PubMed ID: 34928187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Influencing COVID-19 Vaccine Acceptance in High Income Countries Prior to Vaccine Approval and Rollout: A Narrative Review.
    Steffens MS; Bullivant B; Bolsewicz K; King C; Beard F
    Int J Public Health; 2022; 67():1604221. PubMed ID: 35250430
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use.
    Palache A; Rockman S; Taylor B; Akcay M; Billington JK; Barbosa P;
    Vaccine; 2021 Oct; 39(41):6081-6087. PubMed ID: 34521551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes and costs of global COVID-19 vaccine inequity.
    Ferranna M
    Semin Immunopathol; 2024 Jan; 45(4-6):469-480. PubMed ID: 37870569
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.